Skip to main content
. 2022 Mar 7;19(5):3123. doi: 10.3390/ijerph19053123

Table 4.

Characteristics between fallers with and without injuries.

Variables All Fallers
(n = 204)
Fallers
with Injuries
(n = 89)
Fallers
without Injuries
(n = 115)
Χ2 or
t Value
p-Value
Female, n (%) 157 68 (76) 89 (77) 0.03 0.9
Age, mean (SD) (years) 87.3 87.1 (6.6) 87.4 (6.4) −0.39 0.7
Length of stay, median (IQR) (days) 148 (0–776) 169 (0–872) 120 (0–649) 1.26 0.2
No. of all drugs §, median (IQR) 5 (3–7) 5 (3–6.5) 4 (2–7) 0.61 0.3
Polypharmacy §,¶, n (%) 105 52 (58) 53 (46) 3.07 0.08
No. of psychotropic drugs §, median (IQR) 1 (0–2) 1 (0–2) 1 (0–2) 0.12 0.8
Psychotropic drugs §, n (%) 115 53 (60) 62 (54) 0.65 0.4
BZDRAs §, n (%) 68 32 (36) 36 (31) 0.49 0.5
Antipsychotic drugs §, n (%) 59 25 (28) 34 (30) 0.05 0.8
Antiepileptic drugs §, n (%) 38 15 (17) 23 (20) 0.07 0.6
Antidepressant drugs §, n (%) 16 4 (4) 12 (10) 2.59 0.1
Antihypertensive drugs §, n (%) 95 43 (48) 52 (45) 0.19 0.7
Dementia, n (%) 181 82 (92) 99 (86) 1.89 0.2
Charlson Comorbidity Index, median (IQR) 1 (1–3) 1 (1–3) 1 (1–3) 0.46 0.6
Body mass index, median (IQR) 20.3 (18.0–22.3) 20.2 (18.1–22.0) 20.3 (17.8–22.5) −0.21 0.8
Barthel Index, median (IQR) 65 (45–80) 70 (50–90) 50 (40–75) 4.30 <0.0001
Barthel Index ≥ 60 (independent, mildly dependent), n (%) 114 64 (72) 50 (43) 16.8 <0.0001

SD, standard deviation; IQR, interquartile range; BZDRAs, benzodiazepine receptors agonists (benzodiazepines and non-benzodiazepines); § Presence of prescriptions at the beginning of this study. The number of medications was five or more at the beginning of this study.